Literature DB >> 9522789

Association of glutamine 27 polymorphism of beta 2 adrenoceptor with reported childhood asthma: population based study.

E Hopes1, C McDougall, G Christie, J Dewar, A Wheatley, I P Hall, P J Helms.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9522789      PMCID: PMC28470          DOI: 10.1136/bmj.316.7132.664

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

1.  The glutamine 27 beta2-adrenoceptor polymorphism is associated with elevated IgE levels in asthmatic families.

Authors:  J C Dewar; J Wilkinson; A Wheatley; N S Thomas; I Doull; N Morton; P Lio; J F Harvey; S B Liggett; S T Holgate; I P Hall
Journal:  J Allergy Clin Immunol       Date:  1997-08       Impact factor: 10.793

2.  Association of Glu 27 beta 2-adrenoceptor polymorphism with lower airway reactivity in asthmatic subjects.

Authors:  I P Hall; A Wheatley; P Wilding; S B Liggett
Journal:  Lancet       Date:  1995-05-13       Impact factor: 79.321

3.  Continuing increase in respiratory symptoms and atopy in Aberdeen schoolchildren.

Authors:  M Omran; G Russell
Journal:  BMJ       Date:  1996-01-06

4.  Influence of beta 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells.

Authors:  S A Green; J Turki; P Bejarano; I P Hall; S B Liggett
Journal:  Am J Respir Cell Mol Biol       Date:  1995-07       Impact factor: 6.914

5.  Respiratory symptoms and atopy in Aberdeen schoolchildren: evidence from two surveys 25 years apart.

Authors:  T K Ninan; G Russell
Journal:  BMJ       Date:  1992-04-04
  5 in total
  12 in total

Review 1.  Pharmacogenetics of asthma.

Authors:  A Fenech; Ian P Hall
Journal:  Br J Clin Pharmacol       Date:  2002-01       Impact factor: 4.335

Review 2.  Beta-adrenoceptor polymorphisms.

Authors:  K Leineweber; R Büscher; H Bruck; O-E Brodde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-28       Impact factor: 3.000

3.  Beta2-adrenergic receptor polymorphisms are associated with asthma and COPD in adults.

Authors:  Melanie C Matheson; Justine A Ellis; Joan Raven; David P Johns; E Haydn Walters; Michael J Abramson
Journal:  J Hum Genet       Date:  2006-09-01       Impact factor: 3.172

4.  Sequence, haplotype, and association analysis of ADRbeta2 in a multiethnic asthma case-control study.

Authors:  Gregory A Hawkins; Kelan Tantisira; Deborah A Meyers; Elizabeth J Ampleford; Wendy C Moore; Barbara Klanderman; Stephen B Liggett; Stephen P Peters; Scott T Weiss; Eugene R Bleecker
Journal:  Am J Respir Crit Care Med       Date:  2006-08-24       Impact factor: 21.405

Review 5.  Asthma in Hispanics.

Authors:  Gary M Hunninghake; Scott T Weiss; Juan C Celedón
Journal:  Am J Respir Crit Care Med       Date:  2005-10-06       Impact factor: 21.405

6.  Lack of association of TIM3 polymorphisms and allergic phenotypes.

Authors:  Jian Zhang; Denise Daley; Loubna Akhabir; Dorota Stefanowicz; Moira Chan-Yeung; Allan B Becker; Catherine Laprise; Peter D Paré; Andrew J Sandford
Journal:  BMC Med Genet       Date:  2009-06-30       Impact factor: 2.103

7.  Beta 2-adrenergic receptor polymorphism and susceptibility to primary congenital and primary open angle glaucoma.

Authors:  Kivanc Güngör; Mehtap Ozkur; Ingolf Cascorbi; Jürgen Brockmöller; Necdet Bekir; Ivar Roots; A Sükrü Aynacioglu
Journal:  Eur J Clin Pharmacol       Date:  2003-09-12       Impact factor: 2.953

Review 8.  Pharmacogenetics, pharmacogenomics and airway disease.

Authors:  Ian P Hall
Journal:  Respir Res       Date:  2001-11-26

Review 9.  Association studies for asthma and atopic diseases: a comprehensive review of the literature.

Authors:  Sabine Hoffjan; Dan Nicolae; Carole Ober
Journal:  Respir Res       Date:  2003-12-04

10.  Association between β2-adrenoceptor gene polymorphisms and asthma risk: an updated meta-analysis.

Authors:  Haojun Xie; Yuanxiong Cheng; Yating Huo; Guohua Huang; Jin Su
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.